Recovery-Oriented Outcomes Associated with Long-Acting Injectable Antipsychotics in an Urban Safety-Net Population.
Depot medications
Long-acting injectable antipsychotic medications
Psychosis
Recovery
Schizophrenia
Journal
Community mental health journal
ISSN: 1573-2789
Titre abrégé: Community Ment Health J
Pays: United States
ID NLM: 0005735
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
20
11
2018
accepted:
13
05
2019
pubmed:
19
5
2019
medline:
30
9
2020
entrez:
19
5
2019
Statut:
ppublish
Résumé
This study examined whether transitioning patients from oral antipsychotics (POs) to long-acting injectable antipsychotics (LAIs) helps patients achieve recovery-oriented goals. Data was extracted from San Francisco County's electronic medical record system for this retrospective pre-post observational study. Patients reflect a safety-net population treated in community-based mental health settings during 2015. The San Francisco Adult Strengths and Needs Assessment (SF ANSA), a measure of psychosocial functioning, was used to assess within-subject change when treated with POs versus LAIs. In our study sample (N = 77), LAI SF ANSA scores showed significant improvements in criminal behaviors (p = .017), medication adherence (p = .008), and spirituality (p = .028), and a non-significant trend for residential stability (p = .073). This is the first study to evaluate improvements in key psychosocial areas after treatment with LAIs. This work suggests that LAIs can be another tool for providers to help patients work towards their recovery-oriented goals.
Identifiants
pubmed: 31102164
doi: 10.1007/s10597-019-00412-w
pii: 10.1007/s10597-019-00412-w
doi:
Substances chimiques
Antipsychotic Agents
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
979-982Références
J Clin Psychiatry. 2009 Jul;70(7):990-6
pubmed: 19497244
N Engl J Med. 2011 Mar 3;364(9):842-51
pubmed: 21366475
J Clin Epidemiol. 2013 Aug;66(8 Suppl):S37-41
pubmed: 23849151
Patient Prefer Adherence. 2013 Nov 13;7:1171-80
pubmed: 24265549
J Manag Care Spec Pharm. 2015 Sep;21(9):754-68
pubmed: 26308223
Soc Psychiatry Psychiatr Epidemiol. 2016 Dec;51(12):1623-1632
pubmed: 27338740
Psychiatr Serv. 2017 Apr 1;68(4):324-329
pubmed: 27842472
Curr Treat Options Psychiatry. 2017;4(2):117-126
pubmed: 28580230
Schizophr Res. 2018 Apr;194:39-46
pubmed: 28601497
J Clin Psychopharmacol. 2017 Dec;37(6):702-707
pubmed: 28930768
Psychiatr Serv. 2018 Mar 1;69(3):259-267
pubmed: 29191141